Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Luo, Fengling ^a   Sun, Xiaoming ^a   Wang, Yubin ^a   Wang, Qilong ^a   Wu, Yanhong ^a   Pan, Qin ^a   Fang, Chao ^b   Zhang, Xiao Lian ^a  

^a WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN 2; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 17; INTERLEUKIN 6; NITRIC OXIDE; RECOMBINANT PROTEIN; STREPTOMYCIN; STRESS ACTIVATED PROTEIN KINASE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LUNG ALVEOLUS CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; OPSONOPHAGOCYTOSIS; PHAGOCYTOSIS; PHARMACOLOGICAL BLOCKING; SURVIVAL TIME; TUBERCULOSIS;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOLIPIDS; HUMANS; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LECTINS; MACROPHAGES; MALE; MEMBRANE LIPIDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PHOSPHORYLATION; PNEUMOCYTES; PROTEIN BINDING; TUBERCULOSIS; VIRULENCE; YOUNG ADULT;

EID: 84883647779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073859     Document Type: Article

References (44)

1. Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, et al. (2008) Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA 300: 2153-2160. doi:10.1001/jama.300.18.2153. PubMed: 19001626.
2. Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, et al. (2008) Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 22: 2527-2533. doi:10.1097/QAD.0b013e328311ac4e. PubMed: 19005276.
3. Fujita T, (2002) Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2: 346-353. doi:10.1038/nri800. PubMed: 12033740.
4. Fujita T, Matsushita M, Endo Y, (2004) The lectin-complement pathway--its role in innate immunity and evolution. Immunol Rev 198: 185-202. doi:10.1111/j.0105-2896.2004.0123.x. PubMed: 15199963.
5. Endo Y, Sato Y, Matsushita M, Fujita T, (1996) Cloning and characterization of the human lectin P35 gene and its related gene. Genomics 36: 515-521. doi:10.1006/geno.1996.0497. PubMed: 8884275.
6. Le Y, Lee SH, Kon OL, Lu J, (1998) Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett 425: 367-370. doi:10.1016/S0014-5793(98)00267-1. PubMed: 9559681.
7. Sugimoto R, Yae Y, Akaiwa M, Kitajima S, Shibata Y, et al. (1998) Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem 273: 20721-20727. doi:10.1074/jbc.273.33.20721. PubMed: 9694814.
8. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, et al. (2005) Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 175: 3150-3156. PubMed: 16116205.
9. Kwon S, Kim MS, Kim D, Lee KW, Choi SY, et al. (2007) Identification of a functionally relevant signal peptide of mouse ficolin A. J Biochem Mol Biol 40: 532-538. doi:10.5483/BMBRep.2007.40.4.532. PubMed: 17669269.
10. Endo Y, Liu Y, Kanno K, Takahashi M, Matsushita M, et al. (2004) Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human pp. L/M-ficolins. Genomics 84: 737-744.
11. Nahid AM, Sugii S, (2006) Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria. Dev Comp Immunol 30: 335-343. doi:10.1016/j.dci.2005.04.002. PubMed: 15964070.
12. Taira S, Kodama N, Matsushita M, Fujita T, (2000) Opsonic function and concentration of human serum ficolin/P35. Fukushima J Med Sci 46: 13-23. PubMed: 11446374.
13. Aoyagi Y, Adderson EE, Min JG, Matsushita M, Fujita T, et al. (2005) Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci. J Immunol 174: 418-425. PubMed: 15611266.
14. Krarup A, Mitchell DA, Sim RB, (2008) Recognition of acetylated oligosaccharides by human L-ficolin. Immunol Lett 118: 152-156. doi:10.1016/j.imlet.2008.03.014. PubMed: 18486240.
15. Krarup A, Sørensen UB, Matsushita M, Jensenius JC, Thiel S, (2005) Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 73: 1052-1060. doi:10.1128/IAI.73.2.1052-1060.2005. PubMed: 15664949.
16. Runza VL, Schwaeble W, Männel DN, (2008) Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 213: 297-306. doi:10.1016/j.imbio.2007.10.009. PubMed: 18406375.
17. Endo Y, Takahashi M, Iwaki D, Ishida Y, Nakazawa N, et al. (2013) Mice defieient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection. J Immunol 189: 5860-5866.
18. Ma Y, Chen HD, Wang Y, Wang Q, Li Y, et al. (2011) Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection. Microbes Infect 13: 1099-1110. doi:10.1016/j.micinf.2011.06.012. PubMed: 21787878.
19. Pan Q, Chen H, Wang F, Jeza VT, Hou W, et al. (2012) L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun 4: 312-324. doi:10.1159/000335670. PubMed: 22399010.
20. Kaur D, Obregón-Henao A, Pham H, Chatterjee D, Brennan PJ, et al. (2008) Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase. Proc Natl Acad Sci U S A 105: 17973-17977. doi:10.1073/pnas.0807761105. PubMed: 19004785.
21. Liu J, Ali MA, Shi Y, Zhao Y, Luo F, et al. (2009) Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 6: 235-244. doi:10.1038/cmi.2009.32. PubMed: 19728924.
22. Fujimori Y, Harumiya S, Fukumoto Y, Miura Y, Yagasaki K, et al. (1998) Molecular cloning and characterization of mouse ficolin-A. Biochem Biophys Res Commun 244: 796-800. doi:10.1006/bbrc.1998.8344. PubMed: 9535745.
23. O'Rourke JP, Newbound GC, Kohn DB, Olsen JC, Bunnell BA, (2002) Comparison of Gene Transfer Efficiencies and Gene Expression Levels Achieved with Equine Infectious Anemia Virus- and Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors. J Virol 76: 1510-1515. doi:10.1128/JVI.76.3.1510-1515.2002. PubMed: 11773424.
24. Lehmann AK, Sornes S, Halstensen A, (2000) Phagocytosis: measurement by flow cytometry. J Immunol Methods 243(1-2):: 229-242. doi:10.1016/S0022-1759(00)00237-4. PubMed: 10986417.
25. Karlsson A, Christenson K, Matlak M, Björstad A, Brown KL, Telemo E, Salomonsson E, et al. (2009) Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology 19: 16-20. PubMed: 18849325.
26. Tsuji S, Taniuchi S, Hasui M, Yamamoto A, Kobayashi Y, (2002) Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 7: 283-288. doi:10.1016/S1089-8603(02)00110-6. PubMed: 12446177.
27. Zhou J, Cheung AK, Tan Z, Wang H, Yu W, et al. (2013) PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest 123: 2629-2642. doi:10.1172/JCI64704. PubMed: 23635778.
28. Kilpatrick DC, Fujita T, Matsushita M, (1999) P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol Lett 67: 109-112. doi:10.1016/S0165-2478(98)00147-3. PubMed: 10232391.
29. Hu YL, Luo FL, Fu JL, Chen TL, Wu SM, et al. (2013) Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients. Scand J Immunol 77: 144-150. doi:10.1111/sji.12014. PubMed: 23298162.
30. Greco E, Santucci MB, Sali M, De Angelis FR, Papi M, et al. (2010) Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells. Immunology 129: 125-132. doi:10.1111/j.1365-2567.2009.03145.x. PubMed: 19878354.
31. Atkinson AP, Cedzynski M, Szemraj J, St Swierzko A, Bak-Romaniszyn L, et al. (2004) L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 138: 517-520. doi:10.1111/j.1365-2249.2004.02634.x. PubMed: 15544630.
32. Hummelshøj T, Munthe-Fog L, Madsen HO, Garred P, (2008) Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol 45: 2508-2520. doi:10.1016/j.molimm.2008.01.003. PubMed: 18289682.
33. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, et al. (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 14: 1651-1658. doi:10.1093/hmg/ddi173. PubMed: 15879437.
34. Kilpatrick DC, Chalmers JD, (2012) Human L-ficolin (ficolin-2) and its clinical significance. J Biomed Biotechnol,(2012): pp. 138797. PubMed: 22500076.
35. Lacroix M, Dumestre-Pérard C, Schoehn G, Houen G, Cesbron JY, et al. (2009) Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J Immunol 182: 456-465. PubMed: 19109177.
36. Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, et al. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192: 237-248. doi:10.1084/jem.192.2.237. PubMed: 10899910.
37. Sica A, Mantovani A, (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795. PubMed: 22378047.
38. Nauciel C, Espinasse-Maes F, (1992) Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 60: 450-454. PubMed: 1730475.
39. Robinson CM, Jung JY, Nau GJ, (2012) Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages. Cytokine 60: 233-241. doi:10.1016/j.cyto.2012.06.012. PubMed: 22749533.
40. Curtis MM, Way SS, (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185. doi:10.1111/j.1365-2567.2008.03017.x. PubMed: 19125888.
41. Nagabhushanam V, Solache A, Ting LM, Escaron CJ, Zhang JY, et al. (2003) Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J Immunol 171: 4750-4757. PubMed: 14568951.
42. Karin M, (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486. PubMed: 7622446.
43. Davis RJ, (1994) MAPKs: new JNK expands the group. Trends Biochem Sci 19: 470-473. doi:10.1016/0968-0004(94)90132-5. PubMed: 7855889.
44. Super M, Levinsky RJ, Turner MW, (1990) The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol 79: 144-150. doi:10.1111/j.1365-2249.1990.tb05170.x. PubMed: 2311294.